Given Imaging (GIVN) Tops Q2 View
More News related to GIVN
- Given Imaging (GIVN) Announces the Degree of Impact the PillCam SB has on GI Patients, Crohn's Disease
- Three Studies Find PillCam(R) SB Enables Earlier Diagnosis and Treatment of GI Diseases Including Crohn's
- Given Imaging (GIVN) Announces Viability of PillCam Capsule in Pediatric Patients
- Given Imaging Announces RAPID(R) pH Software for Bravo(R) pH Monitoring System
- New Studies Show PillCam(R) SB to Be Clinically Valuable in Classifying and Managing Pediatric GI Symptoms
More News related to Earnings
- Highlights From SWHC Q2 Conference Call: First Qtr Reflected Results From Two Segments Under S&W Umbrella; Guides Below for Q3
- NASB Financial (NASB) Posts Q4 EPS of $0.77, Tops Views
- Highlights From Take-Two Interactive Softwares' (TTWO) Forecast Teleconference
- Saks (SKS) Restates Q3 EPS to $0.04, Up from $0.01
- Big Lots (BIG) Delivers With Strong Q3 Results and Guidance
Given Imaging Ltd. (Nasdaq: GIVN) reports Q2 EPS of $0.09, 7 cents better than the analyst estimate of $0.02. Revenues for the quarter were $33.1 million, versus the consensus of $32.07 million.
Related Categories
EarningsStocks Mentioned
+0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
